17.3 USD
+0.29 (+1.7%)
At close: Jan 30, 2026
17.027 USD
-0.27 (-1.58%)
After Hours: 1/30/2026, 8:00:00 PM
ADMA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While ADMA has a great health rating, its profitability is only average at the moment. ADMA is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make ADMA a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- ADMA had positive earnings in the past year.
- In the past year ADMA had a positive cash flow from operations.
- ADMA had negative earnings in 4 of the past 5 years.
- In multiple years ADMA reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 36.83%, ADMA belongs to the top of the industry, outperforming 98.86% of the companies in the same industry.
- ADMA's Return On Equity of 48.57% is amongst the best of the industry. ADMA outperforms 98.67% of its industry peers.
- With an excellent Return On Invested Capital value of 25.76%, ADMA belongs to the best of the industry, outperforming 98.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 36.83% | ||
| ROE | 48.57% | ||
| ROIC | 25.76% |
ROA(3y)4.32%
ROA(5y)-9.88%
ROE(3y)-2.53%
ROE(5y)-28.83%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ADMA's Profit Margin of 42.87% is amongst the best of the industry. ADMA outperforms 98.10% of its industry peers.
- Looking at the Operating Margin, with a value of 34.19%, ADMA belongs to the top of the industry, outperforming 97.52% of the companies in the same industry.
- ADMA has a Gross Margin of 54.71%. This is in the better half of the industry: ADMA outperforms 76.76% of its industry peers.
- In the last couple of years the Gross Margin of ADMA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.19% | ||
| PM (TTM) | 42.87% | ||
| GM | 54.71% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y226.2%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ADMA is creating value.
- Compared to 1 year ago, ADMA has more shares outstanding
- ADMA has more shares outstanding than it did 5 years ago.
- ADMA has a better debt/assets ratio than last year.
2.2 Solvency
- ADMA has an Altman-Z score of 19.70. This indicates that ADMA is financially healthy and has little risk of bankruptcy at the moment.
- ADMA has a Altman-Z score of 19.70. This is amongst the best in the industry. ADMA outperforms 89.14% of its industry peers.
- ADMA has a debt to FCF ratio of 1.78. This is a very positive value and a sign of high solvency as it would only need 1.78 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 1.78, ADMA belongs to the top of the industry, outperforming 93.71% of the companies in the same industry.
- ADMA has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
- ADMA's Debt to Equity ratio of 0.16 is on the low side compared to the rest of the industry. ADMA is outperformed by 64.57% of its industry peers.
- Even though the debt/equity ratio score it not favorable for ADMA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.78 | ||
| Altman-Z | 19.7 |
ROIC/WACC2.9
WACC8.89%
2.3 Liquidity
- ADMA has a Current Ratio of 7.13. This indicates that ADMA is financially healthy and has no problem in meeting its short term obligations.
- ADMA has a Current ratio of 7.13. This is in the better half of the industry: ADMA outperforms 70.67% of its industry peers.
- A Quick Ratio of 3.65 indicates that ADMA has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.65, ADMA is in line with its industry, outperforming 46.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.13 | ||
| Quick Ratio | 3.65 |
3. Growth
3.1 Past
- ADMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.86%, which is quite impressive.
- Looking at the last year, ADMA shows a very strong growth in Revenue. The Revenue has grown by 27.62%.
- ADMA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 70.84% yearly.
EPS 1Y (TTM)92.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)27.62%
Revenue growth 3Y74.04%
Revenue growth 5Y70.84%
Sales Q2Q%12%
3.2 Future
- Based on estimates for the next years, ADMA will show a very strong growth in Earnings Per Share. The EPS will grow by 33.00% on average per year.
- Based on estimates for the next years, ADMA will show a very strong growth in Revenue. The Revenue will grow by 21.50% on average per year.
EPS Next Y19.34%
EPS Next 2Y35.12%
EPS Next 3Y33.64%
EPS Next 5Y33%
Revenue Next Year20.85%
Revenue Next 2Y22.49%
Revenue Next 3Y22.24%
Revenue Next 5Y21.5%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 32.04, ADMA can be considered very expensive at the moment.
- ADMA's Price/Earnings ratio is rather cheap when compared to the industry. ADMA is cheaper than 93.14% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.30, ADMA is valued at the same level.
- With a Price/Forward Earnings ratio of 18.95, ADMA is valued on the expensive side.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ADMA indicates a rather cheap valuation: ADMA is cheaper than 94.48% of the companies listed in the same industry.
- ADMA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.04 | ||
| Fwd PE | 18.95 |
4.2 Price Multiples
- ADMA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ADMA is cheaper than 93.90% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADMA indicates a rather cheap valuation: ADMA is cheaper than 91.43% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 101.39 | ||
| EV/EBITDA | 23.2 |
4.3 Compensation for Growth
- ADMA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of ADMA may justify a higher PE ratio.
- A more expensive valuation may be justified as ADMA's earnings are expected to grow with 33.64% in the coming years.
PEG (NY)1.66
PEG (5Y)N/A
EPS Next 2Y35.12%
EPS Next 3Y33.64%
5. Dividend
5.1 Amount
- ADMA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ADMA BIOLOGICS INC / ADMA FAQ
What is the fundamental rating for ADMA stock?
ChartMill assigns a fundamental rating of 7 / 10 to ADMA.
What is the valuation status of ADMA BIOLOGICS INC (ADMA) stock?
ChartMill assigns a valuation rating of 6 / 10 to ADMA BIOLOGICS INC (ADMA). This can be considered as Fairly Valued.
How profitable is ADMA BIOLOGICS INC (ADMA) stock?
ADMA BIOLOGICS INC (ADMA) has a profitability rating of 6 / 10.
What is the financial health of ADMA BIOLOGICS INC (ADMA) stock?
The financial health rating of ADMA BIOLOGICS INC (ADMA) is 8 / 10.